Sherman J. Silber, MD. Director of The Infertility Center of St. Louis, Missouri. USA:
Studies show that if you are pregnant with COVID-19 there is no harm to the fetus. Careful scientific studies also show that certain drugs such as Chloroquine are extremely effective in treating the virus. In addition, experimental studies have shown that getting plenty of sleep can improve resistance to the virus. There are many myths and rumors about this virus, but the data below from well-established academic centers will detail the validity of the above statements. -Dr. Sherman Silber
Advisory Board’s Dr. Sherman Silber Shares Infertility Techniques in China
Global Thinking – News and Views From the College of Arts & Sciences at Webster University April 4, 2012
Sherman Silber, M.D., a member of the College of Arts & Sciences Advisory Board and a renowned pioneer in microsurgery and infertility, recently traveled to Guagzhou, China, on the invitation of Chinese medical experts. While in China, he shared his techniques for ovary freezing and transplantation, and led a team of surgeons in performing that country’s first ovarian tissue transplant.
This innovative technology is primarily used to preserve fertility for cancer patients. The treatment method also provides options for women who want to preserve their fertility in order to put off childbearing until later in life.
During his China trip, Silber also received an honorary degree and full professor faculty position at the prestigious Sun Yat-sen University Medical School.
Silber is considered one of the world’s leading authorities on vasectomy reversal and tubal ligation reversal surgery. He performed the world’s first microsurgical vasectomy reversal, as well as the first testicle transplant and the world’s first ovary transplant. Silber is the author of three medical textbooks, four best-selling books for the layperson, and more than 150 scientific papers on human infertility and reproduction. He appears frequently in the media and was one of four physicians picked to be on the U.S. Congress Office of Technology Assessment study to help infertile couples in the United States.